Cargando…

Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: Impact on diagnostic accuracy and inter-reader agreement

PURPOSE: To assess the value of the PI-RADS 2.1 scoring system in the detection of prostate cancer on multiparametric MRI in comparison to the standard PI-RADS 2.0 system and to assess its inter-reader variability. MATERIALS AND METHODS: This IRB-approved study included 229 patients undergoing multi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hötker, Andreas M., Blüthgen, Christian, Rupp, Niels J., Schneider, Aurelia F., Eberli, Daniel, Donati, Olivio F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535021/ https://www.ncbi.nlm.nih.gov/pubmed/33017413 http://dx.doi.org/10.1371/journal.pone.0239975

Ejemplares similares

PI-RADS 2.1 und strukturierte Befundung der Magnetresonanztomographie der Prostata
por: Hötker, Andreas, et al.
Publicado: (2021)

Value of an online PI-RADS v2.1 score calculator for assessment of prostate MRI
por: Barth, Borna K., et al.
Publicado: (2021)

Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [(68)Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1
por: Zhao, Jing, et al.
Publicado: (2020)

PI-RADS v2.1: What has changed and how to report
por: Scott, Robin, et al.
Publicado: (2021)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
por: Wang, Yu-Hao, et al.
Publicado: (2023)

Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
por: Brancato, Valentina, et al.
Publicado: (2020)

Diagnostic accuracy and inter-observer agreement with the CO-RADS lexicon for CT chest reporting in COVID-19
por: Nair, Anirudh Venugopalan, et al.
Publicado: (2021)

Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study)
por: Di Franco, Florian, et al.
Publicado: (2023)

Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer
por: Li, Mou, et al.
Publicado: (2021)

Impact of PI-RADS v2 on indication of prostate biopsy
por: Rozas, George de Queiroz, et al.
Publicado: (2019)

Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021)

Standards for MRI reporting—the evolution to PI-RADS v 2.0
por: Spektor, Michael, et al.
Publicado: (2017)

Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study
por: Cai, Guan-Hui, et al.
Publicado: (2021)

Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions
por: Brancato, Valentina, et al.
Publicado: (2021)

The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)
por: Liu, Jiazhou, et al.
Publicado: (2022)

Intraobserver and Interobserver Agreement between Six Radiologists Describing mpMRI Features of Prostate Cancer Using a PI-RADS 2.1 Structured Reporting Scheme
por: Jóźwiak, Rafał, et al.
Publicado: (2023)

(68)Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement
por: Ferraro, Daniela A., et al.
Publicado: (2022)

Local staging of prostate cancer with multiparametric-MRI: accuracy and inter-reader agreement
por: Popiţa, Cristian, et al.
Publicado: (2020)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
por: Wen, Jing, et al.
Publicado: (2022)

Machine learning-based analysis of a semi-automated PI-RADS v2.1 scoring for prostate cancer
por: Singh, Dharmesh, et al.
Publicado: (2022)

Standardization of Multiparametric Prostate MR Imaging Using PI-RADS
por: Bomers, Joyce G. R., et al.
Publicado: (2014)

Prostate MRI based on PI-RADS version 2: how we review and report
por: Steiger, Philipp, et al.
Publicado: (2016)

Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer
por: Rudolph, Madhuri Monique, et al.
Publicado: (2020)

A nomogram based on PI-RADS v2.1 and clinical indicators for predicting clinically significant prostate cancer in the transition zone
por: Wei, Chaogang, et al.
Publicado: (2021)

Lesion Volume in a Bi- or Multivariate Prediction Model for the Management of PI-RADS v2.1 Score 3 Category Lesions
por: Martorana, Eugenio, et al.
Publicado: (2022)

Study of iron metabolism based on T2* mapping sequences in PI-RADS 3 prostate lesions
por: D, Wenhao, et al.
Publicado: (2023)

Rad51 paralogs Rad55-Rad57 balance the anti-recombinase Srs2 in Rad51 filament formation
por: Liu, Jie, et al.
Publicado: (2011)

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
por: Wang, Changming, et al.
Publicado: (2022)

MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
por: Chen, Tong, et al.
Publicado: (2022)

Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsies
por: Wang, Yunhan, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis of American College of Radiology TI-RADS Inter-Reader Reliability for Risk Stratification of Thyroid Nodules
por: Li, Wei, et al.
Publicado: (2022)

Development and internal validation of PI-RADs v2-based model for clinically significant prostate cancer
por: Zhang, Yu, et al.
Publicado: (2018)

Inter-subunit interactions that coordinate Rad51's activities
por: Grigorescu, Arabela A., et al.
Publicado: (2009)

Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
por: Jin, Pengfei, et al.
Publicado: (2022)

Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy
por: Fujimoto, Ayumi, et al.
Publicado: (2023)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
por: Aliukonis, Paulius, et al.
Publicado: (2017)

The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3
por: Zhu, Hai, et al.
Publicado: (2022)

Roles of XRCC2, RAD51B and RAD51D in RAD51-Independent SSA Recombination
por: Serra, Heïdi, et al.
Publicado: (2013)

Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels
por: Pricolo, Paola, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m9d6ii943ionjed9p5sj8mj80k